Big Pharma don’t have time for micro biotechs when it’s cheaper to do everything in-house these days with the tech that they have at their disposal
BIT have to send all n sundry to third parties to generate results
These third parties have a huge backlog of tests and demand premium prices
meanwhile big pharma produce the commercial goods
Big Pharma don’t have time for micro biotechs when it’s cheaper...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.005(11.1%) |
Mkt cap ! $45.11M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 5.2¢ | 4.6¢ | $42.25K | 871.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 155000 | 2 |
View Market Depth
| Last trade - 15.51pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
0.005 ( 8.70 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 5.1¢ | 4.6¢ | 221683 | ||
| Last updated 15.49pm 14/06/2024 ? | |||||
| BIT (ASX) Chart |